advanced search

Latest Issue

ORAL DRUG DELIVERY187

Issue No #187  June 29th, 2026


Download PDF


Issue 187 - Jun 2026

Inside the magazine

ROLLER COMPACTION IN MODERN ORAL SOLID DOSE DEVELOPMENT
GI/ORAL
David O’Connell
PCI Pharma Services
ROLLER COMPACTION IN MODERN ORAL SOLID DOSE DEVELOPMENT
David O’Connell  delves into oral solid dosage production, highlighting the advantages of roller compaction for sensitive drugs as well as the possibilities for integration into existing manufacturing lines.
MICRONISATION SUCCESS STARTS WITH SOLID-STATE UNDERSTANDING
GI/ORAL
Derek Beauchamp
Catalent Pharma Solutions
MICRONISATION SUCCESS STARTS WITH SOLID-STATE UNDERSTANDING
Dr Derek Beauchamp and John Kusnierz explain how solid-state characterisation underpins the behaviour of a drug substance under processing conditions, and consider the importance of micronisation in improving bioavailability and drug product performance.
ORAL DELIVERY OF MACROMOLECULES: CHALLENGES AND OPPORTUNITIES FOR DEVICE-ENABLED GI DELIVERY
EXPERT VIEW
Dr Sahab Babaee
ORAL DELIVERY OF MACROMOLECULES: CHALLENGES AND OPPORTUNITIES FOR DEVICE-ENABLED GI DELIVERY
Dr Sahab Babaee discusses the potential of device-based approaches to enable the delivery of macromolecules via the gastrointestinal tract, considering the constraints and possibilities of mucosal delivery devices, as well as the technologies currently being investigated to make this potential a reality.
INTELLIGENT INTEGRATION: WHY CONNECTED OSD ECOSYSTEMS ARE RESHAPING PHARMACEUTICAL MANUFACTURING
GI/ORAL
Borja Guerra
ACG
INTELLIGENT INTEGRATION: WHY CONNECTED OSD ECOSYSTEMS ARE RESHAPING PHARMACEUTICAL MANUFACTURING
Borja Guerra delves into how the oral solid dosage manufacturing industry is being reshaped by connected machinery, advanced digital systems and integrated supplier ecosystems across the production process.
ADVANCING ORAL BIOLOGIC DELIVERY: OVERCOMING BARRIERS TO ENABLE INNOVATION AND ACCESS
GI/ORAL
Dr Vincent Jannin
Lonza
ADVANCING ORAL BIOLOGIC DELIVERY: OVERCOMING BARRIERS TO ENABLE INNOVATION AND ACCESS
Dr Vincent Jannin considers the advantages of delivering biologic medications, including glucagon-like peptide-1s, via oral delivery and discusses the technological strides being made towards enabling biologics to shift away from parenteral delivery.
Top